MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
AEON — AEON Biopharma, Inc.
NYSE AmericanAEON Biopharma, Inc.
$0.29
-0.01(-3.33%)
- O
- 0.30
- H
- 0.33
- L
- 0.28
- V
- 6.43M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About AEON
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 24, 2023
Employees8
Stock ExchangeNYSE American
Ticker SymbolAEON
Key Financial Statistics
| Market Cap | $13.15M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.18 - $1,236.24 |
| 52-Week Avg Volume | 885.3K |
| VWAP | $0.31 |
| Transactions | 12,209 |
| Total Recorded Bars | 940 days |